STATEMENT OF OPERATIONS - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|---|
Dec. 31, 2020 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Sep. 30, 2021 |
|
| CONDENSED STATEMENTS OF OPERATIONS | |||||
| Formation cost | $ 3,543 | $ 1,018,418 | $ 1,456,685 | ||
| Net Income (loss) | $ (3,543) | $ (40,521) | $ 8,318,874 | $ (1,154,131) | $ 7,124,222 |
| Weighted-average shares outstanding, basic (in shares) | 7,500,000 | 8,625,000 | 8,381,868 | ||
| Weighted-average shares outstanding, diluted (in shares) | 7,500,000 | 8,625,000 | 8,381,868 | ||
| Basic net income (loss) per share (in dollar per share) | $ 0.00 | $ 0.00 | $ 0.20 | ||
| Diluted net income (loss) per share (in dollar per share) | $ 0.00 | $ 0.00 | $ 0.20 | ||
| Loss from operations | $ (1,018,418) | $ (1,456,685) | |||
| Other income/(expense) | |||||
| Unrealized loss on change in fair value of warrants | 951,443 | 9,341,215 | |||
| Transaction costs allocated to warrant liabilities | (820,691) | ||||
| Interest income | 26,454 | 60,383 | |||
| Total other income | $ 977,897 | $ 8,580,907 | |||
| X | ||||||||||
- Definition Amount of transaction costs allocated to warrant liabilities. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|